was thinking 5.60 in PM was too low and we might test 6. LOL this took a #$%$. I am ready to give up. I'll never see my 150K out of this company. Hope berger gets run over crossing the street.
what a pos stock. sell the company berger for $10 and be done with it. get better people in there to push the stock higher. what junk. should have sold some at PM and gotten some money out. trash and going nowhere.
you're worth 105B. what's 4B to you??? buy us out and read the rewards. don't be stupid amgn mgt. beat nvs, gsk, mrk, pfe, biib, celg, gild, bmy, azn, sny, and a host of others.
just wish something would get done. look at all the bios. mc's are huge. amgn, celg, biib, gild, to name a few. use the high stock price to buy us out. geez, endo is 10B and they bought out auxl at 2.6B.
that just seems too low even without me being biased at a 20 price that I bought at. if inclusig works on other indications or front line, and with 26113 given star status, they'd have to go higher on the bid. 15 minimum is my guess. the problem with ARIA vs. other bios is that they have 185MM shares. dopes diluted way too much. they also have way too many employees for the products/sales they have. get rid of 50% of workers and things improve (cash flow).
for denner having an average of 3.86 or so, 9-12 is a huge multiple. for us longs who bought before October 9th, that range is 15-25 if I recall correctly. doubt anyone would accept a 12 offer. 20 maybe. but with 20 comes a 4B MC so that's a lot with the current sales. if that mystery drug worked, then 25 or more is in the cards. I can be on berger's side if he says no to 12 buyout. too low.
MRK buys some firm that has a preclinical candidate for 4B and we get the 26113 data and nothing as we know it so far. This should be circled by big pharma like crazy now. #$%$???????? get rid of the poison pill and berger. he's the poison for longs.
I thought the lung 26113 data and the priority review was big. the stock isn't showing it but the FDA gave priority review and that is usually worth a lot. I'll take 4B takeout now. I think the bio space is way overvalued and they should use their inflated stock to do a deal before MR. Market dives and they dive too.
with celg, gild, amgn, biib, (to name a few), having their stocks so high, it would be in their best interest to buyout ARIA for say 5B and get the whole company and grow further.
What's BTD??? as for FDA approving 26113, that will take about 3-4 years from now till they run PhII and PhIII trials. We've got a long time for that my friend.
if this drug were that good, pharma would offer $50 tomorrow. on 60 minutes now, they are saying glevic is the best drug out there and lets patients live 10 years.
then tell NVS, PFE, AMGN, CELG, BIIB, BMY, AZN,..... Need I go on??? just offer $25-30 and it will be gobbled up.
and the board idiot resurfaces. go away.
man, if it was close to 10, we'd be at 9 in PM. we might click 6. then the shorts will try to take it down. we need a buyout news format at $25 and then it will spike.
if that mystery drug had a good trial soon, we'd get a buyout asap as all 3 drugs are clicking. I say 25-30. what hurss us is the high outstanding shares. now we know why denner wants more shares and wants another seat and buyout. he knew the news.